Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies

Kobayashi, Roger H ; Gupta, Sudhir ; Melamed, Isaac ; Mandujano, J Fernando ; Kobayashi, Ai Lan ; Ritchie, Bruce ; Geng, Bob ; Atkinson, Thomas Prescott ; Rehman, Syed ; Turpel-Kantor, Eva ; Litzman, Jiří

Frontiers in immunology, 2019-02, Vol.10, p.40 [Periódico revisado por pares]

Switzerland: Frontiers Media S.A

Texto completo disponível